A highly sensitive immuno-PCR method specific for the detection of antigens of and antibodies to bovine herpesvirus 1 was established. This assay attained a high sensitivity of up to 10 7.0 times higher than that of enzyme-linked immunosorbent assay (ELISA) or PCR for antigen detection and 10 5.0 times higher than that of ELISA for antibody detection.
ature. After the wells were washed with PBS supplemented with 0.5% Tween 20 (PBST), 50 l of 1.5 ϫ 10 Ϫ21 mol of the marker DNA in PBS5T was added to each well and incubated. The plates were washed 10 times and subjected to PCR (7) . One microliter each of PC1 and PC2 (50 pmol), 4 l of deoxynucleoside triphosphates (10 mM), 5 l of 10ϫ reaction buffer (Perkin-Elmer), 5 l of MgCl 2 (25 mM), and 1 l (1 U) of AmpliTaq DNA polymerase (Perkin-Elmer) were added to each well, mixed, and overlaid with 40 l of mineral oil. Thirtyfive amplification cycles were carried out in a PTC-100 programmable thermal controller (MJ Research, Inc.); 95ЊC, 1 min of denaturation, 58ЊC, 1 min of annealing, and 72ЊC, 2 min of extension, and final extension, 72ЊC for 5 min. The product size, 191 bp, predicted upon the published gene sequence (12) , was visualized by electrophoresis in 2% agarose gels containing ethidium bromide. No amplification product was detected when one of the following materials was omitted: antigen FIG. 1. Schematic presentation of immuno-PCR for the detection of BHV-1. The ELISA plate was coated with antigen. BHV-1-specific monoclonal antibody, biotin-labeled goat anti-mouse antibody, streptavidin, and biotin-labeled marker DNA were added sequentially. Blocking with 1% BSA was done after the plate was coated with antigen. The plates were washed with PBST 5 (a) or 10 (b) times. Finally, the plates were subjected to PCR. For antibody detection, the test serum was added in place of monoclonal antibody against BHV-1.
(BHV-1), primary antibody (anti-gB of BHV-1), secondary antibody (biotinylated goat anti-mouse), streptavidin, marker DNA, Taq polymerase, or primers (data not shown).
For antigen detection, the culture supernatant of MDBK cells infected with BHV-1 or nasal secretions of the calves were centrifuged at low speed and serial 10-fold dilutions in PBS were prepared. Each dilution was treated with disruption buffer (0.05 M Tris-HCl [pH 7.8], 0.5% Triton X-100, 0.6 M KCl). Each well of 96-well plates (Falcon 3911; Becton Dickinson) was coated with 50 l of each dilution at 4ЊC overnight. The plates were blocked with 1% BSA in PBS. Fifty microliters of monoclonal antibody 2G6-51 against the gB of BHV-1 (5), diluted 1/2,000 in PBS5T, was added to each well. Biotinlabeled goat antibodies specific to mouse immunoglobulin G Fc (EY Laboratories, Inc.) diluted 1/2,000 in PBS5T were then added. Immuno-PCR/Ag detected the antigen in the culture supernatant (10 7 .0 PFU/ml) up to a dilution of 1:10 9.9 ( Fig. 2a) . ELISA detected the antigen up to a dilution of 1:10 4.9 ( Fig. 2b ) of the same sample. Results obtained from three independent tests with the same sample are summarized in Table 1 . Immuno-PCR/Ag was up to 10 3.7 , 10 7.0 , and 10 6.9 more sensitive than plaque-forming assay, ELISA, and PCR, respectively.
For the detection of antibodies in the rabbit anti-BHV-1 immune serum or sera obtained from the experimentally infected calves, serial twofold dilutions in PBS5T were added to the BHV-1-coated plates. Biotinylated goat anti-rabbit or antibovine immunoglobulin G Fc (EY Laboratories, Inc.) antibodies diluted 1/3,000 in PBS5T, respectively, were then added. The results showed that immuno-PCR/Ab was 10 5 times more sensitive than ELISA (data not shown).
All calves infected with BHV-1 developed various degrees of the clinical signs ( Table 2) . On 1 dpi, virus was recovered from 6 of the 8 calves while viral antigen was detected in all the calves by immuno-PCR/Ag. No more virus shedding was detected by the virus isolation assay after 10 dpi, while viral antigen continued to be detected by immuno-PCR/Ag. All samples negative by immuno-PCR/Ag were negative by virus isolation as well. A large number of those samples negative by a The BHV-1 infectious cell culture supernatant was diluted as described in the text.
b The results are shown as log 10 reciprocal of the highest dilution that was positive for BHV-1. Numbers in parentheses are the results of a set of experiments performed on the same sample by each assay. 
a Calves 1 to 8 were intranasally inoculated with BHV-1. b The symbols ϩ and Ϫ indicate positive and negative results, respectively. For clinical signs, a positive result indicates the presence of at least one of the following: fever, nasal mucosal lesions, nasal discharge, dyspnea, conjunctivitis, and depression. In all cases, the severe clinical signs were observed only up to 10 dpi. VOL. 34, 1996 NOTES 749 at HOKKAIDO DAIGAKU on August 28, 2007
jcm.asm.org virus isolation were positive by immuno-PCR/Ag. From 14 to 21 dpi, some of the samples were negative probably because of reduced antigen presence. ELISA on the test sera of the calves 7 days prior to vaccination gave antibody-negative results. Immuno-PCR/Ab performed on the same samples detected two positive samples, with a titer of 1:10 4.6 (data not shown), probably because of the presence of colostrally acquired maternal antibodies (2) .
An immuno-PCR assay based on biotinylated anti-species antibodies and the primers from the ori gene of pUC19 provided a practical means of detecting BHV-1 infection with a sensitivity higher than those of plaque-forming assay, ELISA, and PCR. The sensitivity and specificity of the present modified method compare favorably with those reported previously (4, 6, 8, 9, 13) . Whereas the plaque-forming assay detects infectious BHV-1 particles only, immuno-PCR/Ag detects the physical particles and free gB antigen. The sensitivity of a PCR assay on BHV-1 detection in nasal swabs was found to be at least as high as that of virus isolation (11) with extensive purification of the template DNA from the sample.
We conclude that immuno-PCR/Ag and immuno-PCR/Ab are more sensitive than any existing tests for antigen and antibody detection, respectively, and thus may become the assays of choice for the routine diagnosis of not only BHV-1 infection but also other infections.
